The Ablate-by-LAW Study

NACompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

November 21, 2020

Primary Completion Date

July 20, 2022

Study Completion Date

July 20, 2022

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

Personalized atrial fibrillation ablation

Atrial fibrillation (AF) ablation adapting the ablation index (AI) target in a point-by-point manner, according the local left atrial wall thickness (LAWT), as measured by multidetector cardiac tomography (MDCT)

Trial Locations (5)

Unknown

Herz- und Diabeteszentrum Nordrhein-Westfalen, Bad Oeynhausen

Heart Center Leipzig University Hospital, Leipzig

Azienda Ospedaliero-Universitaria Pisana, Pisa

Puerta del Mar University Hospital, Cadiz

08022

Teknon Medical Center, Barcelona

All Listed Sponsors
collaborator

Heart and Diabetes Center North Rhine-Westphalia

OTHER

collaborator

Azienda Ospedaliero, Universitaria Pisana

OTHER

collaborator

Heart Center Leipzig - University Hospital

OTHER

collaborator

Hospital Universitario Puerta del Mar

OTHER

lead

Centro Medico Teknon

OTHER

NCT04218604 - The Ablate-by-LAW Study | Biotech Hunter | Biotech Hunter